• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Senseonics

How CGM tech has advanced in the 21st century

March 11, 2021 By Brian Buntz

The rapid evolution of the continuous glucose monitor (CGM) has brought flexibility and convenience to diabetes control. Continuous glucose monitors (CGMs) have transformed how many people with diabetes manage blood sugar, but attempts to monitor blood glucose have a long history. Efforts to manage glucose kicked off in earnest when researchers began measuring glucose in […]

Filed Under: Business/Financial News, Diabetes, Diagnostics, Digital Health, Drug Pumps, Drug-Device Combinations, Featured Tagged With: Abbott, CGM, Dexcom, Medtronic, Senseonics

MedTech 100 roundup: Industry sees largest fall since October

March 8, 2021 By Sean Whooley

The medtech industry’s hot start to 2021 has finally come to a full halt after stocks fell harder than they had in more than four months. MassDevice‘s MedTech 100 index ended the week (March 5) at 103.3 points, marking a -3.1% dip from the 106.65-point mark set one week before (Feb. 26). In less than a […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Amgen, Asensus Surgical, BD, becton dickinson, Boston Scientific, Colfax Corp., conformis, coronavirus, COVID-19, Five Prime Therapeutics, GSL Solutions, Hillrom, LivaNova, MedTech 100 Index, Medtronic, Permira, Senseonics, TransEnterix

Senseonics sinks on mixed bag Q4, massive bottom-line slide

March 5, 2021 By Sean Whooley

Senseonics (NYSE:SENS) shares took a hit today on fourth-quarter losses that missed the consensus earnings forecast. SENS shares were hit hard at market close yesterday after financial results were released, dipping -15.7% to $2.69 per share. In pre-market trading this morning, they are down -7.8% at $2.48 per share. The Germantown, Md.-based implantable continuous glucose monitor […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Wall Street Beat Tagged With: Senseonics

EmblemHealth to provide coverage for Senseonics’ Eversense CGM

January 20, 2021 By Sean Whooley

Senseonics (NYSE:SENS) announced that EmblemHealth is now providing coverage for its Eversense continuous glucose monitoring system. Germantown, Md.-based Senseonics said in a news release that the immediately effective decision adds to the number of payers writing the Eversense system into their CGM coverage policies and paying for the healthcare provider’s time for the in-office sensor placement. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring Tagged With: Senseonics

Senseonics announces $50M from stock offering

January 19, 2021 By Sean Whooley

Senseonics (NYSE:SENS) announced that it entered into securities purchase agreements worth gross proceeds of approximately $50 million. Germantown, Md.-based Senseonics’ purchase agreements are with several healthcare-focused investors, as well as other institutional investors, according to a news release. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring Tagged With: Senseonics

How much is COVID-19 affecting procedure volumes for medtech?

October 22, 2020 By Sean Whooley

UBS Financial Services released a report detailing how it expects medtech procedures to potentially keep dipping during the COVID-19 pandemic. The report highlighted a quicker-than-expected recovery in the second quarter after U.S. hospitals began canceling, delaying and deferring elective procedures in late March as the pandemic took hold. However, UBS still expects third-quarter medical procedures […]

Filed Under: Business/Financial News, Featured, Surgical Tagged With: Baxter, becton dickinson, Boston Scientific, coronavirus, COVID-19, Dexcom, Insulet, Masimo, Medtronic, Senseonics, Stryker, UBS, Zimmer Biomet

MedTech 100 roundup: Up-and-down week for industry

August 17, 2020 By Sean Whooley

Medtech stocks highlighted the topsy-turvy nature of the market last week, but ultimately finished the seven days nearly unchanged. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.77 points at the end of last week (Aug. 14). Overall, medtech stocks saw a 0.13% increase from the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: becton dickinson, Celularity, coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Hologic, Livongo, MedTech 100 Index, Medtronic, Qiagen N.V., Quidel Corp., Sanuwave, Senseonics, Thermo Fisher Scientific, Ventec Life Systems, Vingroup

Senseonics posts mixed bag Q2, partners with Ascensia

August 11, 2020 By Sean Whooley

Senseonics (NYSE:SENS) shares rose slightly today on second-quarter results that were mixed compared to the consensus forecast. The Germantown, Md.-based implantable continuous glucose monitor maker also announced a deal with Ascensia Diabetes Care for global commercialization and distribution with concurrent financing worth up to $50 million. Senseonics posted losses of -$7.5 million, or -3¢ per share, […]

Filed Under: Business/Financial News, Diabetes, Distribution, Featured, Funding Roundup, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Ascensia Diabetes Care, phcholdings, Senseonics

MedTech 100 roundup: Markets skid after strong stretch

June 15, 2020 By Sean Whooley

Following a strong performance over the last couple of weeks, the medtech market experienced one of its most significant drop-offs in recent months amid investor worries over a rise in COVID-19 cases in some states. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.12 points at […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, MassDevice Earnings Roundup, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: Abbott, Dow Jones, Grifols, Hologic, MedTech 100 Index, Moderna, Okami Medical, S&P, Senseonics

Senseonics plummets on big Q1 losses

June 10, 2020 By Sean Whooley

Senseonics (NYSE:SENS) shares took a large dip today on first-quarter losses that came in well short of the consensus forecast. The Germantown, Md.-based implantable continuous glucose monitor maker posted losses of -$42.6 million, or -21¢ per share, on sales of $31,000 for the three months ended March 31, 2020, for a 45% bottom-line slide on a […]

Filed Under: Business/Financial News, Diabetes, MassDevice Earnings Roundup, Patient Monitoring, Wall Street Beat Tagged With: Senseonics

Cutera, Senseonics and more receive Paycheck Protection Program loans

April 27, 2020 By Sean Whooley

A number of medtech companies announced that they received millions of dollars in loans through the Paycheck Protection Program of the Coronavirus Aid, Relief and Economic Security (CARES) Act. Cutera (NSDQ:CUTR), Senseonics (NYSE:SENS), Viveve Medical (NSDQ:VIVE) and Encision (ECIA:ECIA) received approximately $15 million combined through the program administered by the U.S. Small Business Administration amid the COVID-19 pandemic. […]

Filed Under: Business/Financial News, Diabetes, Funding Roundup, Surgical, Women's Health Tagged With: coronavirus, COVID-19, Cutera Inc., Encision Inc., Senseonics, Viveve, Viveve Medical

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS